Meyka Pro banner
Aclarion, Inc.

Aclarion, Inc. (ACON) Stock Overview

Explore Aclarion, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACONNASDAQ
HealthcareMedical - Healthcare Information Services
$2.42
$0.03(1.22%)
U.S. Market opens in 63h 27m

Aclarion, Inc. (ACON)

Meyka AI Score

Z

Key Financials

Market Cap1.3M
P/E Ratio-0.26
EPS (TTM)$-10.62
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 Month$2.31
3 Months$0.00
1 Year Target$0.00

ACON Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Aclarion, Inc. (NASDAQ: ACON) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Aclarion, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACON on the NASDAQ shows an RSI of 26.49, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Aclarion, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.26 and a market capitalization of 1.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACON on the NASDAQ.

Price Performance (NASDAQ: ACON)

1-Day Change
-1.22%
5-Day Change
-7.28%
1-Month Change
-11.68%
3-Month Change
-26.67%
6-Month Change
-36.32%
Year-to-Date (YTD) Change
-47.39%
1-Year Change
-66.98%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

650-241-1741
8181 Arista Place, Broomfield, CA, 94404

Company Facts

110 Employees
IPO DateApr 22, 2022
CountryUS
Actively Trading

Frequently Asked Questions